Actelion Ltd is a biopharmaceutical company with its corporate 
headquarters in Allschwil/ Basel, Switzerland. Its first drug Tracleer® 
has been approved as a therapy for pulmonary arterial hypertension and is 
marketed through subsidiaries in key markets worldwide. As a leading 
player in innovative science related to the endothelium, which separates 
every blood vessel from the blood stream, Actelion focuses on the 
discovery, development and marketing of innovative drugs for significant 
unmet medical needs. Actelion shares are traded on the SWX Swiss Exchange 
(ticker symbol: ATLN).

In the Genomics Core Unit of Actelion we are currently looking for a

Microarray Data Analyst 

In this position you will be responsible for the following: 

Analysis of microarray data and evaluation and integration of new analysis 
methods

The ideal candidate should have:
At least a master degree and possibly a PhD in Biostatistics or Biology 
with strong background in statistics and with significant experience in 
microarray data analysis
Experience using R and bioconductor is required
Strong communication skills and fluency in English
Flexibility and enthusiasm to work in an interdisciplinary team
We offer:
a competitive salary with attractive fringe benefits 
the innovative and stimulating research atmosphere of an expanding company

The research facilities are located in Allschwil, Switzerland, a suburb of 
Basel on the borders of France and Germany.


Please send a comprehensive application in English to:
Daniela Schuster, Human Resources Manager
ACTELION Pharmaceuticals Ltd
Gewerbestrasse 16, 4123 Allschwil / Switzerland
e-mail: jobs.ch@actelion.com


--------------------------------------------------------------------------------------------------------
Yasmina Bauer, PhD
Lab Head Molecular Biology
Actelion Pharmaceuticals Ltd / Gewerbestrasse 16 / CH-4123 Allschwil  / 
Switzerland /
phone +41 61 565 63 65  / fax +41 61 565 65 00 / 
yasmina.bauer@actelion.com / www.actelion.com
Address for visitors: Hegenheimermattweg 91






The information of this email and in any file transmitted with it is strictly confidential and may be legally privileged.
It is intended solely for the addressee. If you are not the intended recipient, any copying, distribution or any other use of this email is prohibited and may be unlawful. In such case, you should please notify the sender immediately and destroy this email.
The content of this email is not legally binding unless confirmed by letter.
Any views expressed in this message are those of the individual sender, except where the message states otherwise and the sender is authorised to state them to be the views of the sender's company. For further information about Actelion please see our website at http://www.actelion.com 


	[[alternative HTML version deleted]]

